JENNIFER BLAYLOCK: Open Payments
NPI 1235457631 · MELISSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 15 payments from 10 companies in 2025. Trend: 2023 $371 · 2024 $594 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $54 |
| Dexcom, Inc. | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $32 |
| Antares Pharma, Inc. | 2 | $30 |
| ABBVIE INC. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Cipher Pharmaceuticals US LLC | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: TRELEGY ELLIPTA, Dexcom G6 Transmitter, VOQUEZNA, MOUNJARO, XYOSTED, QULIPTA, REXULTI, Natroba.
Industry payments across TX — which companies pay providers there.
